<html>
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="viewport" content="width=device-width,initial-scale=1,minimum-scale=1,maximum-scale=1,user-scalable=no" />
    <meta http-equiv="X-UA-Compatible" content="ie=edge">
    <title>乳腺癌临床试验</title>
    <link rel="stylesheet" href="./comment.css">
    <link rel="stylesheet" href="./index.css">
</head>
<body>
    <ul>
        <a href="./test/thirdTest.html"><li>一项在激素受体阳性、HER2 阴性的局部复发或转移性乳腺癌绝经后女性中开展的比较NSAI（阿那曲唑或来曲唑）联用CDK4 和CDK6 抑制剂Abemaciclib 或安慰剂以及比较氟维司群联用Abemaciclib 或安慰剂的随机化、双盲、安慰剂对照的3 期研究</li><a/>
    </ul>
</body>
</html>